Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-001978-22Phase 2Active
Phase 2, open-label trial of sodium thiosulfate in calcinosis and ectopic ossification (HO) (3 arms), sponsored by CHU de Limoges. Primary endpoint: Primary: Percentage change in calcification/ossification volume from M6 to M12. Started Sep 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-001978-22.